Arrowhead Pharmaceuticals Inc

ARWR
stockHealthcareBiotechnology
$6/day into ARWR since 2015 would be worth $142,642 today — 8.3× the money.
Try your own number →

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference (RNAi) mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.

Description from Wikipedia · CC BY-SA 4.0
Read more on Wikipedia →

If you'd bought from year…

Same habit, different start year. Each row shows what a constant habit's worth of ARWR would be worth today, had you started buying at that point in the asset's history.

Started$6/day$6/day coffee$42/wk$42/week coffee
Year 1 (1993) — listing
$358,950
7.3×
$522,186
7.3×
Year 6 (1998)
$354,939
8.3×
$516,563
8.3×
Year 11 (2003)
$323,951
9.2×
$471,065
9.2×
Year 16 (2008)
$293,402
10.6×
$426,855
10.6×
Year 21 (2013)
$194,826
9.6×
$282,402
9.6×
Year 26 (2018)
$40,217
3.2×
$59,259
3.2×
Year 31 (2023)
$15,372
3.0×
$22,506
3.0×

Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.

Popular scenarios with ARWR

arrowheadpharma.com

For illustration only — not investment advice. Past performance is not indicative of future results.